technetium tc 99m sestamibi has been researched along with Ductal, Lobular, and Medullary Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christodoulidou, J; Feida, H; Louvrou, A; Michalas, S; Pampouras, G; Papadaki, E; Papantoniou, V; Sotiropoulou, M; Souvatzoglou, M; Valotassiou, V; Zerva, C | 1 |
1 other study(ies) available for technetium tc 99m sestamibi and Ductal, Lobular, and Medullary Neoplasms
Article | Year |
---|---|
Uptake and washout of 99mTcV-dimercaptosuccinic acid and 99mTc-sestamibi in the assessment of histological type and grade in breast cancer.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; False Negative Reactions; Female; Humans; Mammography; Neoplasm Staging; Neoplasms, Ductal, Lobular, and Medullary; Phyllodes Tumor; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi | 2002 |